Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Modifying a budget mid-month can be straightforward. Discover simple tweaks and actionable tips to adjust categories while preserving progress.
20,466 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
On a day shaped by geopolitical optimism, the stock market today showed modest gains as investors priced in the poten...
As AI-driven spend accelerates, Fidelity’s MSCI Industrials ETF has posted solid gains, but a cautious investor may f...
Solana is testing the Alpenglow upgrade with validator trials and a potential Q3 mainnet. Analysts weigh timing, risk...
GraniteShares’ 2x COIN ETF has seen substantial NAV erosion as Coinbase volatility spikes, prompting renewed debate o...
Netflix reports a strong Q1 2026, lifting free cash flow guidance and accelerating ad revenue. Analysts see a path to...
As markets shift in May 2026, a popular plan to generate $4,800 per year from $40,000 in dividend stocks faces realit...
When a top executive sells shares after exercising options, markets take note. This deep dive breaks down Kalvista's ...
Infineon is attracting attention as the market bet grows on AI-driven data-center power needs. The company’s edge in ...
Five-year losses on laddered bonds have stretched retirees' portfolios. If Kevin Warsh takes the helm, his policy cho...
CoreWeave's backlog booming has caught the eye of investors eyeing AI infrastructure. This piece breaks down whether ...
Warner Bros Discovery trades below $30 as streaming momentum and a robust film slate raise bets on a profitability tu...